CN113730487A - 一种清眸抑菌眼液及其制备方法 - Google Patents

一种清眸抑菌眼液及其制备方法 Download PDF

Info

Publication number
CN113730487A
CN113730487A CN202111085561.2A CN202111085561A CN113730487A CN 113730487 A CN113730487 A CN 113730487A CN 202111085561 A CN202111085561 A CN 202111085561A CN 113730487 A CN113730487 A CN 113730487A
Authority
CN
China
Prior art keywords
parts
extract
eye
cleaning
liquid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202111085561.2A
Other languages
English (en)
Inventor
李顾芳
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tianjin Ruyikang Chinese Medicine Technology Co ltd
Original Assignee
Tianjin Ruyikang Chinese Medicine Technology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tianjin Ruyikang Chinese Medicine Technology Co ltd filed Critical Tianjin Ruyikang Chinese Medicine Technology Co ltd
Priority to CN202111085561.2A priority Critical patent/CN113730487A/zh
Publication of CN113730487A publication Critical patent/CN113730487A/zh
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/60Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605Morus (mulberry)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/23Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/232Angelica
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/287Chrysanthemum, e.g. daisy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/35Caprifoliaceae (Honeysuckle family)
    • A61K36/355Lonicera (honeysuckle)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/45Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/482Cassia, e.g. golden shower tree
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/48Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484Glycyrrhiza (licorice)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/56Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/85Verbenaceae (Verbena family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

本发明公开了一种清眸抑菌眼液及其制备方法,涉及眼部保健护理技术领域,针对传统的清眸眼液对缓解视力疲劳、眼干、眼涩等并没有显著的功效等问题,现提出如下方案,所述清眸抑菌眼液包括由以下重量份的原料组成:桑叶提取物20‑25份、甘菊花提取物15‑20份、决明子提取物15‑20份、谷精草提取物8‑11份、蔓荆子提取物4‑7份、密蒙花提取物4‑6份、金银花提取物2‑7份。该清眸抑菌眼液对缓解视力疲劳、眼干、眼涩等有着显著的功效,且对金黄色葡萄球菌、大肠杆菌和白色念珠菌有者很好的抑制作用,同时在当归提取物的作用下能够有效的使其他的有效成分进入眼部基底,发挥其作用,安全性能高,且功效显著。

Description

一种清眸抑菌眼液及其制备方法
技术领域
本发明涉及眼部保健护理技术领域技术领域,尤其涉及一种清眸抑菌眼液及其制备方法。
背景技术
随着社会环境的改变和生产关系的变化,大多数的劳动者需要使用电脑、手机等电子产品,而长期的使用眼睛使得眼睛产生不适,例如眼干、眼涩、眼纹增多等,虽然眼干一般不会引起严重的眼部疾病,但是如果不注意或者处理不当,会引起眼睛受损,甚至引发角膜发炎。
传统的清眸眼液对缓解视力疲劳、眼干、眼涩等并没有显著的功效,且易使使用者产生依赖性,且一般的清眸液并不具备对金黄色葡萄球菌、大肠杆菌和白色念珠菌等微生物有抑制作用,为此,提出了一种清眸抑菌眼液及其制备方法来解决以上问题。
发明内容
(一)发明目的
为解决背景技术中存在的技术问题,本发明提出一种清眸抑菌眼液及其制备方法,该清眸抑菌眼液对缓解视力疲劳、眼干、眼涩等有着显著的功效,且对金黄色葡萄球菌、大肠杆菌和白色念珠菌有者很好的抑制作用,同时在当归提取物的作用下能够有效的使其他的有效成分进入眼部基底,发挥其作用,安全性能高,且功效显著。
(二)技术方案
本发明提供了一种清眸抑菌眼液及其制备方法,所述清眸抑菌眼液包括由以下重量份的原料组成:桑叶提取物20-25份、甘菊花提取物15-20份、决明子提取物15-20份、谷精草提取物8-11份、蔓荆子提取物4-7份、密蒙花提取物4-6份、金银花提取物2-7份、当归提取物2-6份、甘草提取物2-7份、越桔果提取物3-7份、透明质酸钠1-2份、保湿剂1-3份。
优选的,所述桑叶提取物的制备方法如下:将桑叶进行阴干、粉碎、过筛,得到桑叶粉末,加入体积分数为90%乙醇,搅拌均匀,将液体放入超声发生器中,超声10-20min,得到所述桑叶提取物。
优选的,所述甘菊花提取物的制备方法如下:将甘菊花进行干燥、粉碎,加入2-4倍重量份的水和0.05-0.1倍重量份的防腐剂,搅拌均匀,之后水浴加热30-40min,水浴加热完成后进行过滤除杂,之后再用体积分数为75-85%的乙醇进行浓缩,干燥,得到所述甘菊花提取物。
优选的,所述决明子提取物的制备方法如下:将决明子进行干燥、粉碎、研磨,得到决明子粉末,之后加入水,放入超声搅拌器中,超声10-20min,超声完成后进行蒸馏,得到所述决明子提取物。
优选的,所述保湿剂为甘油、丙二醇、山梨醇中的一种或者两种组合。
优选的,所述水浴加热的温度为70-80℃,通过纱布进行过滤除杂。
优选的,所述决明子粉末和水的重量比1:2,所述蒸馏时间为15-20min。
优选的,S1:按照重量份计,取桑叶提取物20-25份、甘菊花提取物15-20 份、决明子提取物15-20份,依次加入搅拌器中搅拌均匀,搅拌时间为20-30min,得到混合液体A;
S2:将混合溶液A、谷精草提取物8-11份、蔓荆子提取物4-7份、密蒙花提取物4-6份、金银花提取物2-7份、当归提取物2-6份、甘草提取物2-7份、越桔果提取物3-7份倒入烧杯中水浴加热30-45min,边加热边搅拌,得到混合液体B;
S3:将装有混合液体B的烧杯取出,将透明质酸钠1-2份、保湿剂1-3份加入烧杯中,放入超声发生器中,超声10-20min,得到清眸抑菌眼液。
优选的,所述水浴加热的温度为55-65℃。
与现有技术相比,本发明的上述技术方案具有如下有益的技术效果:
1、本发明提供的清眸抑菌眼液以桑叶提取物、甘菊花提取物和决明子提取物为主要成分,配合谷精草提取物、蔓荆子提取物、密蒙花提取物、金银花提取物、当归提取物、甘草提取物、越桔果提取物,能够被眼部皮肤很好的吸收,从而使得其他的有效成分进入眼部基底,对缓解视力疲劳、眼干、眼色等有着显著的功效。
2、本发明提供的清眸抑菌眼液以桑叶提取物、甘菊花提取物和决明子提取物为主要成分,对金黄色葡萄球菌、大肠杆菌和白色念珠菌有者很好的抑制作用,且本发明添加有当归提取物,能够有效的使其他的有效成分进入眼部基底,发挥其作用。
具体实施方式
为使本发明的目的、技术方案和优点更加清楚明了,下面结合具体实施方式,对本发明进一步详细说明。应该理解,这些描述只是示例性的,而并非要限制本发明的范围。此外,在以下说明中,省略了对公知结构和技术的描述,以避免不必要地混淆本发明的概念。
实施例1:一种清眸抑菌眼液及其制备方法
包括由以下重量份的原料组成:桑叶提取物25份、甘菊花提取物15份、决明子提取物20份、谷精草提取物6份、蔓荆子提取物5份、密蒙花提取物6 份、金银花提取物5份、当归提取物4份、甘草提取物5份、越桔果提取物4 份、透明质酸钠2份、保湿剂3份。
具体制备方法如下:按照配比称取桑叶提取物25份、甘菊花提取物15份、决明子提取物20份、谷精草提取物6份、蔓荆子提取物5份、密蒙花提取物6 份、金银花提取物5份、当归提取物4份、甘草提取物5份、越桔果提取物4 份、透明质酸钠2份、保湿剂3份;
1)按照重量份计,取桑叶提取物25份、甘菊花提取物15份、决明子提取物20份,依次加入搅拌器中搅拌均匀,搅拌时间为20-30min,得到混合液体 A1;
2)将混合溶液A、谷精草提取物6份、蔓荆子提取物5份、密蒙花提取物 6份、金银花提取物5份、当归提取物4份、甘草提取物5份和越桔果提取物4 份倒入烧杯中水浴加热30-45min,边加热边搅拌,得到混合液体B1;
3)将装有混合液体B的烧杯取出,将透明质酸钠2份、保湿剂3份加入烧杯中,放入超声发生器中,超声10-20min,得到清眸抑菌眼液试件A。
实施例2:一种清眸抑菌眼液及其制备方法
包括由以下重量份的原料组成:桑叶提取物20份、甘菊花提取物20份、决明子提取物20份、谷精草提取物11份、蔓荆子提取物7份、密蒙花提取物 6份、金银花提取物2份、当归提取物5份、甘草提取物3份、越桔果提取物3 份、透明质酸钠2份、保湿剂1份。
具体制备方法如下:按照配比称取桑叶提取物20份、甘菊花提取物20份、决明子提取物20份、谷精草提取物11份、蔓荆子提取物7份、密蒙花提取物 6份、金银花提取物2份、当归提取物5份、甘草提取物3份、越桔果提取物3 份、透明质酸钠2份、保湿剂1份。
1)按照重量份计,取桑叶提取物20份、甘菊花提取物20份、决明子提取物20份,依次加入搅拌器中搅拌均匀,搅拌时间为20-30min,得到混合液体 A2;
2)将混合溶液A、谷精草提取物11份、蔓荆子提取物7份、密蒙花提取物6份、金银花提取物2份、当归提取物5份、甘草提取物3份、越桔果提取物3份倒入烧杯中水浴加热30-45min,边加热边搅拌,得到混合液体B2;
3)将装有混合液体B的烧杯取出,将透明质酸钠2份、保湿剂1份加入烧杯中,放入超声发生器中,超声10-20min,得到清眸抑菌眼液试件B。
实施例3:一种清眸抑菌眼液及其制备方法
包括由以下重量份的原料组成:桑叶提取物25份、甘菊花提取物15份、决明子提取物20份、谷精草提取物8份、蔓荆子提取物5份、密蒙花提取物4 份、金银花提取物5份、当归提取物4份、甘草提取物5份、越桔果提取物4 份、透明质酸钠2份、保湿剂3份。
具体制备方法如下:按照配比称取桑叶提取物25份、甘菊花提取物15份、决明子提取物20份、谷精草提取物8份、蔓荆子提取物5份、密蒙花提取物4 份、金银花提取物5份、当归提取物4份、甘草提取物5份、越桔果提取物4 份、透明质酸钠2份、保湿剂3份。
1)按照重量份计,取桑叶提取物25份、甘菊花提取物15份、决明子提取物20份,依次加入搅拌器中搅拌均匀,搅拌时间为20-30min,得到混合液体 A3;
2)将混合溶液A、谷精草提取物8份、蔓荆子提取物5份、密蒙花提取物 4份、金银花提取物5份、当归提取物4份、甘草提取物5份、越桔果提取物4 份倒入烧杯中水浴加热30-45min,边加热边搅拌,得到混合液体B3;
3)将装有混合液体B的烧杯取出,将透明质酸钠2份、保湿剂3份加入烧杯中,放入超声发生器中,超声10-20min,得到清眸抑菌眼液试件C。
对上述实施例1、实施例2、实施例3所得的清眸抑菌眼液试件A、清眸抑菌眼液试件B、清眸抑菌眼液试件C进行缓解视疲劳效果检测和抑菌效果检测,检测方法如下:筛选100例长期用眼,视力易疲劳的志愿者,随机平均分成四组,第一组使用本发明实施例1提供的清眸抑菌眼液试件A,第二组使用本发明实施例2提供的清眸抑菌眼液试件B,第三组使用本发明实施例3提供的清眸抑菌眼液试件C,第四组不使用任何产品,为空白对照组。第一组、第二组和第三组每天使用一次,每次外服时间15-20min,连续使用10天。测定第二天、第四天、第六天、第八天、第十天明视持久度和对金黄色葡萄球菌的抑菌率(见表一和表二)。
表一
明视持久度 第二天 第四天 第六天 第八天 第十天
第一组 69.35% 69.41% 69.63% 70.32% 71.29%
第二组 69.34% 69.53% 70.01% 70.89% 71.27%
第三组 69.35% 69.39% 69.88% 70.71% 71.18%
第四组 69.21% 69.18% 69.15% 69.07% 69.05%
表二
抑菌率 第二天 第四天 第六天 第八天 第十天
第一组 98.79% 98.88% 99.01% 99.21% 99.23%
第二组 98.77% 98.86% 99.03% 99.23% 99.24%
第三组 98.79% 98.85% 99.12% 99.17% 99.22%
第四组 92.03% 92.01% 92.03% 92.03% 92.02%
经实验测得,清眸抑菌眼液试件A、清眸抑菌眼液试件B、清眸抑菌眼液试件C与空白对照组对比,其缓解视疲劳的效果显著,且添加有当归提取物,能够有效的使其他的有效成分进入眼部基底,同时通过与空白对照组对比,可以得出对金黄色葡萄球菌有着显著的抑制作用的结论。
应当理解的是,本发明的上述具体实施方式仅仅用于示例性说明或解释本发明的原理,而不构成对本发明的限制。因此,在不偏离本发明的精神和范围的情况下所做的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。此外,本发明所附权利要求旨在涵盖落入所附权利要求范围和边界、或者这种范围和边界的等同形式内的全部变化和修改。

Claims (9)

1.一种清眸抑菌眼液及其制备方法,其特征在于,所述清眸抑菌眼液包括由以下重量份的原料组成:桑叶提取物20-25份、甘菊花提取物15-20份、决明子提取物15-20份、谷精草提取物8-11份、蔓荆子提取物4-7份、密蒙花提取物4-6份、金银花提取物2-7份、当归提取物2-6份、甘草提取物2-7份、越桔果提取物3-7份、透明质酸钠1-2份、保湿剂1-3份。
2.根据权利要求1所述的一种清眸抑菌眼液及其制备方法,其特征在于,所述桑叶提取物的制备方法如下:将桑叶进行阴干、粉碎、过筛,得到桑叶粉末,加入体积分数为90%乙醇,搅拌均匀,将液体放入超声发生器中,超声10-20min,得到所述桑叶提取物。
3.根据权利要求1所述的一种清眸抑菌眼液及其制备方法,其特征在于,所述甘菊花提取物的制备方法如下:将甘菊花进行干燥、粉碎,加入2-4倍重量份的水和0.05-0.1倍重量份的防腐剂,搅拌均匀,之后水浴加热30-40min,水浴加热完成后进行过滤除杂,之后再用体积分数为75-85%的乙醇进行浓缩,干燥,得到所述甘菊花提取物。
4.根据权利要求1所述的一种清眸抑菌眼液及其制备方法,其特征在于,所述决明子提取物的制备方法如下:将决明子进行干燥、粉碎、研磨,得到决明子粉末,之后加入水,放入超声搅拌器中,超声10-20min,超声完成后进行蒸馏,得到所述决明子提取物。
5.根据权利要求1所述的一种清眸抑菌眼液及其制备方法,其特征在于,所述保湿剂为甘油、丙二醇、山梨醇中的一种或者两种组合。
6.根据权利要求3所述的一种清眸抑菌眼液及其制备方法,其特征在于,所述水浴加热的温度为70-80℃,通过纱布进行过滤除杂。
7.根据权利要求4所述的一种清眸抑菌眼液及其制备方法,其特征在于,所述决明子粉末和水的重量比1:2,所述蒸馏时间为15-20min。
8.根据权利要求1-7所述的任一种清眸抑菌眼液及其制备方法,其特征在于,包括如下步骤:
S1:按照重量份计,取桑叶提取物10-25份、甘菊花提取物10-15份、决明子提取物10-20份,依次加入搅拌器中搅拌均匀,搅拌时间为20-30min,得到混合液体A;
S2:将混合溶液A、谷精草提取物8-11份、蔓荆子提取物4-7份、密蒙花提取物4-6份、金银花提取物2-7份、当归提取物2-6份、甘草提取物2-7份、越桔果提取物3-7份倒入烧杯中水浴加热30-45min,边加热边搅拌,得到混合液体B;
S3:将装有混合液体B的烧杯取出,将透明质酸钠1-2份、保湿剂1-3份加入烧杯中,放入超声发生器中,超声10-20min,得到清眸抑菌眼液。
9.根据权利要求8所述的任一种清眸抑菌眼液及其制备方法,其特征在于,所述水浴加热的温度为55-65℃。
CN202111085561.2A 2021-09-16 2021-09-16 一种清眸抑菌眼液及其制备方法 Pending CN113730487A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202111085561.2A CN113730487A (zh) 2021-09-16 2021-09-16 一种清眸抑菌眼液及其制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202111085561.2A CN113730487A (zh) 2021-09-16 2021-09-16 一种清眸抑菌眼液及其制备方法

Publications (1)

Publication Number Publication Date
CN113730487A true CN113730487A (zh) 2021-12-03

Family

ID=78739238

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202111085561.2A Pending CN113730487A (zh) 2021-09-16 2021-09-16 一种清眸抑菌眼液及其制备方法

Country Status (1)

Country Link
CN (1) CN113730487A (zh)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN206700305U (zh) * 2016-05-09 2017-12-05 天津市山佳医药科技有限公司 一种具有圆形空腔的热敷眼罩
CN108904709A (zh) * 2018-09-18 2018-11-30 李淑华 一种纯中药眼贴及其制备方法与应用
CN111407613A (zh) * 2020-05-29 2020-07-14 孙凤明 一种治疗视力恢复的方法
CN112933163A (zh) * 2021-02-05 2021-06-11 广州新锐视光学科技有限公司 一种外用治疗视疲劳的中药组合物分类方法和中药眼贴
CN113018340A (zh) * 2020-12-24 2021-06-25 云南百视堂健康管理有限公司 一种治疗屈光不正与眼疾的中药药剂及其制备方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN206700305U (zh) * 2016-05-09 2017-12-05 天津市山佳医药科技有限公司 一种具有圆形空腔的热敷眼罩
CN108904709A (zh) * 2018-09-18 2018-11-30 李淑华 一种纯中药眼贴及其制备方法与应用
CN111407613A (zh) * 2020-05-29 2020-07-14 孙凤明 一种治疗视力恢复的方法
CN113018340A (zh) * 2020-12-24 2021-06-25 云南百视堂健康管理有限公司 一种治疗屈光不正与眼疾的中药药剂及其制备方法
CN112933163A (zh) * 2021-02-05 2021-06-11 广州新锐视光学科技有限公司 一种外用治疗视疲劳的中药组合物分类方法和中药眼贴

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
宋晶: "家制各款经济药茶", 《东方药膳》 *
张洪波: "疏风清目汤治疗流行性出血性结膜炎183例", 《新中医》 *

Similar Documents

Publication Publication Date Title
CN108096112B (zh) 一种具有防腐功效的植物组合物及其制备方法
CN103494741A (zh) 一种用于化妆品的纯天然防腐剂
CN103735467A (zh) 一种天然植物沐浴露及其制备方法
KR20110024315A (ko) 천연 한방원료를 이용한 천연 항균 조성물
CN106377463A (zh) 一种不含防腐剂的保湿爽肤水组合物
CN113730487A (zh) 一种清眸抑菌眼液及其制备方法
CN104666173A (zh) 一种含有杜仲雄花抗菌护肤活性成分的洗手液及其制备方法
CN106390182A (zh) 一种抑菌天然纤维表层卫生巾及其制作方法
CN110628517A (zh) 一种天然可食用洗洁精及其制备方法
CN113318021B (zh) 一种洗手液
CN105640836B (zh) 一种含有荷花活性成分的护肤水及其制备方法
CN106692030A (zh) 一种防止脱发的蜂胶洗发露
CN107440985A (zh) 一种含有植物成分的高效杀菌卫生湿巾及其制备方法
CN105997731A (zh) 一种纳米绿茶免洗凝胶洗手液
CN110604705A (zh) 一种婴儿山茶油护臀膏的配方及制备方法
KR20200031441A (ko) 눈꺼풀 또는 눈주위 세정용 조성물 및 이를 포함하는 패드
CN113201420B (zh) 一种添加植物活性成分的手工皂
CN106726862A (zh) 一种草莓味护肤洗手液
CN102888314A (zh) 一种鲜桑叶洗脸皂
CN106675841B (zh) 中药衣物洗涤剂
CN110760397A (zh) 一种抗菌洁肤皂及其制备方法
CN113318165A (zh) 一种固化巩膜药
CN101461768A (zh) 苯扎溴铵氯己定双胍洗发液
CN112168768A (zh) 一种舒缓抑菌婴儿洗发沐浴泡泡及制备方法
CN113633596A (zh) 一种全效修复抗敏果冻清洁面膜及其制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination